Academic literature on the topic 'Treatment of human diseases and conditions'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Treatment of human diseases and conditions.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Treatment of human diseases and conditions"
Calabrese, EJ, G. Dhawan, R. Kapoor, and WJ Kozumbo. "Radiotherapy treatment of human inflammatory diseases and conditions: Optimal dose." Human & Experimental Toxicology 38, no. 8 (May 6, 2019): 888–98. http://dx.doi.org/10.1177/0960327119846925.
Full textDegterev, Alexei, Dimitry Ofengeim, and Junying Yuan. "Targeting RIPK1 for the treatment of human diseases." Proceedings of the National Academy of Sciences 116, no. 20 (May 2, 2019): 9714–22. http://dx.doi.org/10.1073/pnas.1901179116.
Full textSafarov, M. T., F. A. Khusanbaeva, K. M. Tashpulatova, and A. M. Khodjiberganov. "THE USE OF PLATELET AUTOPLASMA IN THE COMPLEX TREATMENT OF PERIODONTAL DISEASES." UZBEK MEDICAL JOURNAL 2, no. 2 (February 28, 2021): 5–8. http://dx.doi.org/10.26739/2181-0664-2021-2-1.
Full textAntonevich, Natalya, Andrei Hancharou, Oksana Timokhina, Elena Rynda, Yana Minich, Alexander Prokhorov, Tatiana Mokhort, and Konstantin Chizh. "New biomedical cell products for immunotherapy of human diseases." Science and Innovations 2, no. 228 (February 2022): 15–23. http://dx.doi.org/10.29235/1818-9857-2022-2-15-23.
Full textDastoli, Stefano, Steven Paul Nisticò, Pietro Morrone, Cataldo Patruno, Antonio Leo, Rita Citraro, Luca Gallelli, Emilio Russo, Giovambattista De Sarro, and Luigi Bennardo. "Colchicine in Managing Skin Conditions: A Systematic Review." Pharmaceutics 14, no. 2 (January 27, 2022): 294. http://dx.doi.org/10.3390/pharmaceutics14020294.
Full textPrakash, Ravi, Santosh Kumar Yadav, and Syed Shadab Raza. "STEM CELLS THERAPY IN HUMAN WELFARE AND DISEASE." Era's Journal of Medical Research 7, no. 2 (December 2020): 229–34. http://dx.doi.org/10.24041/ejmr2020.39.
Full textRashid, Sulthan Al. "The Role of Probiotics in Various Diseases." International Journal of Human and Health Sciences (IJHHS) 5, no. 3 (February 6, 2021): 375. http://dx.doi.org/10.31344/ijhhs.v5i3.292.
Full textGilmiyarova, Frida Nasyrovna, N. A. Kolotyeva, V. I. Kuzmicheva, O. A. Gusyakova, I. A. Borodina, G. M. Baisheva, and I. A. Selezneva. "BLOOD GROUP AND HUMAN DISEASES (REVIEW OF LITERATURE)." Russian Clinical Laboratory Diagnostics 65, no. 4 (April 15, 2020): 216–21. http://dx.doi.org/10.18821/0869-2084-2020-65-4-216-221.
Full textMNVS, Sandhya, Vanitha K, and Ramesh A. "Chronic Hypoxia as a Potential Factor in Human Life-threatening Diseases." International Journal of Pharmaceutical Sciences and Nanotechnology 10, no. 4 (July 31, 2017): 3759–62. http://dx.doi.org/10.37285/ijpsn.2017.10.4.1.
Full textSachdeva, Aishani, Jerome Gouge, Christos Kontovounisios, Stella Nikolaou, Alan Ashworth, Kenneth Lim, and Irene Chong. "Klotho and the Treatment of Human Malignancies." Cancers 12, no. 6 (June 23, 2020): 1665. http://dx.doi.org/10.3390/cancers12061665.
Full textDissertations / Theses on the topic "Treatment of human diseases and conditions"
Roodhouse, Amanda. "Modeling human leg arteries: a comparison of conditions and diseases." Thesis, Wichita State University, 2011. http://hdl.handle.net/10057/5029.
Full textThesis (M.S.)--Wichita State University, College of Engineering, Dept. of Mechanical Engineering.
Mondal, Utpal Kumar. "CARBONIC ANHYDRASE MODULATORS FOR DETECTION AND TREATMENT OF HUMAN DISEASES." Diss., Temple University Libraries, 2019. http://cdm16002.contentdm.oclc.org/cdm/ref/collection/p245801coll10/id/543241.
Full textPh.D.
Carbonic anhydrases (CAs, EC 4.2.1.1) are a class of metalloenzymes that catalyze the hydration of CO2 under physiologic conditions and are involved in many physiological and pathological processes. Modulation of CA activity, particularly CA inhibition is exploited pharmacologically for the treatment of many diseases such as cancer, glaucoma, edemas, mountain sickness. CA activation has been less frequently investigated till recently. Genetic deficiencies of several CA isozymes are reported in the literature and reflect the important role of carbonic anhydrases in human physiology and homeostasis. Activation of CA isozymes in brain have been correlated recently with spatial learning and memory. Based on these premises, activators of CA isozymes have the potential to alleviate mild dementias and to act as potential nootropic agents. In chapter 3, continuing our long-term interests towards the development of potent and selective CAAs, we carried out X-ray crystallographic studies with a small series of pyridinium histamine derivatives, previously developed as CAAs by our group. This study revealed important insights into the binding of this class of activators into the active site of CA II isozyme. A potent pyridinium histamine CAA 25i was successfully crystallized with CA II isozyme and was found to bind into the hydrophobic region of the active site, with two binding conformations being observed. This is one of the very few X-ray crystal structures of a CAA available. Based on the findings of this X-ray crystallographic study and building on our previously developed ethylene bis-imidazole CAAs, we advanced a novel series of lipophilic bis-imidazoles. Enzymatic assays carried out on purified human CA isozymes revealed several low nanomolar potent activators against various brain-relevant CA isozymes. Bis-imidazole 30e was found to be a nanomolar potent activator for CA IV, CA VA and CA IX. Due to their conjugated structure, these CAAs were also fluorescent and therefore were fully characterized in terms of photophysical properties, with several representatives proving to display very good fluorophores. The very good activation profile against several different CA isozymes, along with excellent fluorescence properties recommend these compounds as great molecular tools for elucidation of role of CA isozymes in brain physiology, as well as towards improvement of memory and learning. Focusing on inhibition of CA isozymes, it must be stressed that over the last decade a clear connection had been established between the expression of CA IX and CA XII and cancer. Since cancer is the second most common cause of death in the world, we explored the possibility to kill cancer cells via inhibition of different CA isozymes present in cancer cells. The membrane bound carbonic anhydrase IX (CA IX) isozyme represents a particularly interesting anticancer target as it is significantly overexpressed in many solid tumors as compared to normal tissues. In malign tissues this CA isozyme was found to play important role in pH homeostasis and promotes tumor cell survival, progression and metastasis. Thus, CA IX represents a potential biomarker and an appealing therapeutic target for the detection and treatment of cancer. CA IX can be targeted either through the development of small or large molecular weight, potent, and selective inhibitors or through the development of CA IX targeted drug delivery systems for selective delivery of potent chemotherapeutic agents. Building on these premises, in this dissertation, we also revealed our continuing efforts towards the development of potent and selective CA IX inhibitors along with their translation into the development of CA IX targeted drug delivery systems. In chapter 4, we designed a series of small molecular weight (MW) ureido 1,3,4-thiadiazole sulfonamide derivatives employing the “tail approach”, through the decoration of established sulfonamide CA inhibitor warheads with different tail moieties via ureido linker. The generated CAIs were tested against tumor associated CA IX and CA XII isozymes and off-target cytosolic isozymes CA I and CA II, and were revealed to be moderate to highly selective and nanomolar, even sub-nanomolar, potent CA IX inhibitors. Several potent pan-inhibitors were also identified in this section. We assessed these CAIs for their in vitro cell killing ability using MDA-MB 231 breast cancer cell line expressing CA IX and CA XII. The most efficient CAI proved to be ureido-1,3,4-thiadiazole-2-sulfonamide 69, which showed subnanomolar potency against purified human CA IX and CA XII isozymes, with good selectivity against CA I and CA II, and consistent, statistically significant cancer cell killing. In Chapter 5, continuing our efforts towards the development of potent and selective CA IX inhibitors, we designed, synthesized, characterized and evaluated a new series of PEGylated 1,3,4-thiadiazole-2-sulfonamide CAIs, bearing different PEG backbone length. We increased the PEG size from 1K to 20K, in order to better understand the impact of the PEG linker length on the in vitro cell killing ability against CA IX expressing cancer cell lines and also against a CA IX negative cell line. In vitro cell viability assays revealed the optimum PEG linker length for this type of bifunctional bis-sulfonamide CAIs in killing the tumor cells. The most efficient PEGylated CAI was found to bis-sulfonamide DTP1K 91, which showed consistent and significant cancer cell killing at concentrations of 10−100 μM across different CA IX and CA XII expressing cancer cell lines. DTP1K 91 did not affect the cell viability of CA IX negative NCI-H23 tumor cells, thus revealing a CA IX mediated cell killing for these inhibitors. In chapter 6, we decided to further explore the possibility of using CA IX as a targeting epitome for the development of a gold nanoparticle-based drug delivery system. We translated the oligoEG- and PEGylated CAI conjugates into efficient targeting ligands for gold nanoparticle decoration along with chemotherapeutic agent doxorubicin (Dox), in a novel multi-ligand gold nanoplatform designed to selectively release the drug intracellularly, in order to enhance the selective tumor drug uptake and tumor killing. We were successful in developing compatible CAI- and Dox- ligands for efficient dual functionalization of gold nanoparticles. Our optimized, CA IX targeted gold nanoplatform was found to be very efficient towards killing HT-29 tumor cells especially under hypoxic conditions, reducing the hypoxia-induced chemoresistance, thus confirmed the potentiating role of CA IX as a targeting epitome.
Temple University--Theses
Masokwane, Patrick Maburu Dintle. "Prevalence of non-AIDS defining conditions and their associations with virologic treatment failure among adult patients on anti-retroviral treatment in Botswana." University of the Western Cape, 2016. http://hdl.handle.net/11394/5247.
Full textBackground: The recognition of HIV/AIDS as a chronic life-long condition globally in recent years has demanded a different perception and an alignment to its association with other chronic diseases. Both HIV and other chronic non-communicable diseases are significant causes of morbidity and mortality. Their combined DALY contributions for Botswana would be significant if research and strategies in controlling these conditions are not put in place. Natural aging and specific HIV-related accelerated aging of patients who are on antiretroviral treatment means that age-related diseases will adversely affect this population. Princess Marina Hospital Infectious Diseases Care Clinic has been in operation since 2002. The clinic has initiated over 16 000 patients on anti-retroviral treatment (ART) since 2002. The current study estimated the prevalence of non-AIDS defining conditions (NADCs) in the attendees of the clinic in 2013. The majority of patients that attended the clinic had been on treatment for over three years with some patients more than ten years. These ART experienced patients were more likely to be susceptible to chronic non-communicable diseases, including non-AIDS defining conditions. The nomenclature used in classification of NADCs in the current study was appropriate for resource-limited settings; because the study setting offered HIV treatment under resources constraints. Aim: The current study characterised non-AIDS defining conditions, and determined their associations with virologic treatment failure in a cohort of patients that were enrolled at Princess Marina Hospital antiretroviral clinic in Gaborone, Botswana. Methods: A retrospective cross sectional study of records of patients who attended the Princess Marina Infectious Diseases Care Clinic in 2013. Stratified random sampling of a total of 228 patients’ records was achieved from a total population of 5,781 records. Data was transcribed into a Microsoft Excel Spreadsheet and then exported to Epi-Info statistical software for analysis. Results: Eighty (35%) cases of NADCs were reported/diagnosed in the study sample; with 27% (n=62) of the patients having at least one condition, 6.7% (n=17) two conditions, and 0.4% (n=1) three conditions. The top prevalent conditions were hypertension (n= 40), hyperlipidaemia (n=7) and lipodystrophy (n=7). The prevalence of NADCs on the various categories of patients compared with the total sample population was as follows: active patients (prevalence ratio= 0.70), transferred out patients (prevalence ratio = 1.24), patients who died (prevalence ratio=2.04) and patients who were lost to follow-up (prevalence ratio =2.86). The prevalence of NADCs was significantly associated with increasing age (p<0.001); having social problems (p=0.028); having been on treatment for over three years (p=0.007); an outcome of death (p = 0.03) and being lost to follow-up (p=0.007). The study showed that being controlled on second line or salvage regimen (p=0.014) and the presence of adherence problems in the past was associated with virologic failure (p=0.008). There was no association of presence of NADCs to virologic failure. Conclusions: There was significant morbidity of non-AIDS defining conditions in the Princess Marina Infectious Diseases Care Clinic shown by a prevalence of NADCs in the clinic of 35% in 2013.The significant associations of the presence of NADCs and virologic failure with outcomes of death and loss to follow-up illustrate the adverse effects that NADCs are having, and calls for strategies to address multi-morbidities in HIV patients on antiretroviral treatment.
Langenhan, Jana [Verfasser]. "Development of specific immunoadsorbers for the treatment of human pemphigus diseases / Jana Langenhan." Lübeck : Zentrale Hochschulbibliothek Lübeck, 2012. http://d-nb.info/1026457408/34.
Full textTalegaonkar, Sonia S. "The Role of Human MSC Derived Exosomes in the Treatment of Periodontal Diseases." VCU Scholars Compass, 2017. http://scholarscompass.vcu.edu/etd/4969.
Full textSimon, Remil B. S., Darshan M. D. Shah, Peter B. S. Blosser, Demetrio M. D. Macariola, and Jeffrey M. D. Carlsen. "Treatment of CMV Vitritis in a Preterm Newborn." Digital Commons @ East Tennessee State University, 2018. https://dc.etsu.edu/asrf/2018/schedule/165.
Full textLai, Wing-hon Kevin, and 黎永漢. "Generation of vasculogenic progenitor cells from human induced pluripotent stem cells for the treatment of cardiovascular diseases." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2013. http://hdl.handle.net/10722/197112.
Full textpublished_or_final_version
Medicine
Doctoral
Doctor of Philosophy
Khalid, Mahwish Rani, and Mahwish Rani Khalid. "Line1: Implications in the Etiology of Human Diseases, Clinical Utilities, and Pharmacological Target for Disease Treatment." Thesis, The University of Arizona, 2017. http://hdl.handle.net/10150/626716.
Full textLi, Xiang, and 李想. "Effects of human mesenchymal stem cells on cigarette smoke-induced lung damage." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2012. http://hub.hku.hk/bib/B49618209.
Full textpublished_or_final_version
Medicine
Master
Master of Philosophy
Chacko, Anu. "Comparison of human and animal Chlamydia pneumoniae responses to interferon gamma and penicillin treatment." Thesis, Queensland University of Technology, 2015. https://eprints.qut.edu.au/85438/1/Anu_Chacko_Thesis.pdf.
Full textBooks on the topic "Treatment of human diseases and conditions"
Batten, Donna, and Paul Schummer. Human diseases and conditions. Farmington Hills, Mich: Charles Scribner's Sons, 2016.
Find full textKumar, Sunil, Niharika Chandra, Leena Singh, Muhammad Zaffar Hashmi, and Ajit Varma, eds. Biofilms in Human Diseases: Treatment and Control. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-30757-8.
Full textAlderson, W. E. Treatment of skin diseases: Viral conditions. Bradford: University of Bradford School of Studies in Pharmacology, 1985.
Find full textAcupuncture: Treatment of musculoskeletal conditions. Oxford: Butterworth-Heinemann, 2001.
Find full textFrazier, Margaret Schell. Essentials of human diseases and conditions. 4th ed. St. Louis, Mo: Saunders/Elsevier, 2009.
Find full textA, Drzymkowski Jeanette, and Doty Sandra J, eds. Essentials of human diseases and conditions. Philadelphia: Saunders, 1996.
Find full textFrazier, Margaret Schell. Essentials of human diseases and conditions. 4th ed. St. Louis, Mo: Saunders/Elsevier, 2009.
Find full textWist, Drzymkowski Jeanette, ed. Essentials of human diseases and conditions. 3rd ed. St. Louis, MO: Saunders, 2000.
Find full textD, Goodman Herbert, and Buff Sheila, eds. Treating digestive conditions. New York: Berkley Books, 1997.
Find full textBorland, Douglas M. The treatment of certain heart conditions by homoeopathy. New Delhi: Jain, 1987.
Find full textBook chapters on the topic "Treatment of human diseases and conditions"
Arechavala-Gomeza, Virginia, and Alejandro Garanto. "Antisense RNA Therapeutics: A Brief Overview." In Methods in Molecular Biology, 33–49. New York, NY: Springer US, 2022. http://dx.doi.org/10.1007/978-1-0716-2010-6_2.
Full textBenenson, Efim. "Treatment-Induced and Associated Conditions and Diseases." In Rheumatology, 177–82. London: Springer London, 2010. http://dx.doi.org/10.1007/978-1-84996-462-3_12.
Full textNayak, Satish K. "Biofilm-mediated Gastrointestinal Diseases." In Biofilms in Human Diseases: Treatment and Control, 167–76. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-30757-8_12.
Full textDubey, Seema, Shirish Dubey, Ajay Gupta, and Vikash Sharma. "Biofilm-Mediated Dental Diseases." In Biofilms in Human Diseases: Treatment and Control, 91–116. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-30757-8_7.
Full textBacchi, Cyrus J., Robert T. Jacobs, and Nigel Yarlett. "New Developments in the Treatment of Late-Stage Human African Trypanosomiasis." In Trypanosomatid Diseases, 515–29. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA, 2013. http://dx.doi.org/10.1002/9783527670383.ch27.
Full textAgotegaray, Mariela. "Human Bone Diseases and Conventional Treatments." In Silica-Based Nanotechnology for Bone Disease Treatment, 25–38. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-64130-6_3.
Full textDas, Surojeet, Shivani Singh, Monica Steffi Matchado, Aashna Srivastava, and Akash Bajpai. "Biofilms in Human Health." In Biofilms in Human Diseases: Treatment and Control, 27–42. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-30757-8_3.
Full textSchulz-Aellen, Marie-Françoise. "Perspectives in the Detection and Treatment of Diseases." In Aging and Human Longevity, 210–27. Boston, MA: Birkhäuser Boston, 1997. http://dx.doi.org/10.1007/978-1-4612-2006-0_14.
Full textSchulz-Aellen, Marie-Françoise. "Perspectives in the Detection and Treatment of Diseases." In Aging and Human Longevity, 210–27. Boston, MA: Birkhäuser Boston, 1997. http://dx.doi.org/10.1007/978-1-4612-2006-0_17.
Full textSchulz-Aellen, Marie-Françoise. "Perspectives in the Detection and Treatment of Diseases." In Aging and Human Longevity, 210–27. Boston, MA: Birkhäuser Boston, 1997. http://dx.doi.org/10.1007/978-1-4612-2448-8_17.
Full textConference papers on the topic "Treatment of human diseases and conditions"
Fayssal, Iyad, and Fadl Moukalled. "A Numerical Analysis of the Hemodynamic Functionality of Human Coronary Stenosis Under Different Physiologic Conditions and Boundary Condition Formulations." In ASME-JSME-KSME 2019 8th Joint Fluids Engineering Conference. American Society of Mechanical Engineers, 2019. http://dx.doi.org/10.1115/ajkfluids2019-4820.
Full textSathyamoorthy, Mohan. "Two Dimensional Finite Element Analysis of Myocardial Infarction in the Human Left Ventricle." In ASME 1997 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 1997. http://dx.doi.org/10.1115/imece1997-0199.
Full textA Concept, Life-Style:. "Tailoring Motivational Mechanisms to Engage Teenagers in Healthy." In Applied Human Factors and Ergonomics Conference. AHFE International, 2021. http://dx.doi.org/10.54941/ahfe100499.
Full textGuelli, Mariana Sandoval Terra Campos, Daniela Bastos de Almeida Zampier, Lorena Araújo Silva Dias, and Marina de Oliveira Nunes Ibrahim. "Creutzfeldt-Jakob Disease - a literature review." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.126.
Full textHuang, Fei-Hui. "The Needs of Smart Medication Reminder for Elderly s." In Applied Human Factors and Ergonomics Conference. AHFE International, 2021. http://dx.doi.org/10.54941/ahfe100523.
Full textTaylor, Charles A. "Clinical Applications of CFD, Visualization and Virtual Reality in Cardiovascular Medicine." In ASME 1998 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 1998. http://dx.doi.org/10.1115/imece1998-0059.
Full textDu, Wei, Kenneth M. Pryse, Judy A. Fee, Elliot L. Elson, and Ruth J. Okamoto. "Vascular Smooth Muscle Cell Mechanics During Cyclic Stretch: Effect of Serum and a Serum Substitute." In ASME 2007 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2007. http://dx.doi.org/10.1115/sbc2007-176205.
Full textTorrissen, Martina, Astrid Nilsson, Binh Minh Trinh, Elisabeth Ytteborg, Gerd Marit Berge, Harald Svenson, Iren Stoknes, and Marta Bou Mira. "Novel n-3 very-long-chain polyunsaturated fatty acids and their potential role in skin tissue." In 2022 AOCS Annual Meeting & Expo. American Oil Chemists' Society (AOCS), 2022. http://dx.doi.org/10.21748/nkdk5807.
Full textSoni, Abhishek, Nupur Bansal, A. K. Dhull, Vivek Kaushal, and A. K. Chauhan. "Pure primary non gestational choriocarcinoma ovary – diagnostic dilemma and treatment intricacy." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685331.
Full textEndovitsky, R. V., E. Yu Tikhomirova, and S. A. Pashayan. "PREVENTION AND TREATMENT OF HUMAN RESPIRATORY DISEASES." In Современные проблемы пчеловодства и апитерапии. Рыбное: Федеральное государственное бюджетное научное учреждение "Федеральный научный центр пчеловодства", 2021. http://dx.doi.org/10.51759/pchel_api_2021_357.
Full textReports on the topic "Treatment of human diseases and conditions"
Li, Yanhui. Efficacy of non-invasive photodynamic therapy for female lower reproductive tract diseases associated with HPV infection: a comprehensive meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, November 2022. http://dx.doi.org/10.37766/inplasy2022.11.0092.
Full textHua, Zi Bo, and Lv Yuan Chen. Human UCB MSC versus placebo for effect on kidney fibrosis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, October 2022. http://dx.doi.org/10.37766/inplasy2022.10.0104.
Full textBorder, Peter, and Erin Cullen. The Microbiome and Human Health. Parliamentary Office of Science and Technology, May 2018. http://dx.doi.org/10.58248/pn574.
Full textYang, Xinwei, Huan Tu, and Xiali Xue. The improvement of the Lower Limb exoskeletons on the gait of patients with spinal cord injury: A protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, August 2021. http://dx.doi.org/10.37766/inplasy2021.8.0095.
Full textZheng, Ruo-xiang, Xun Li, Jing Li, Zhen-wei Liu, Feng Jiang, Nicola Robinson, and Jian-ping Liu. Does Chinese herbal remedy Tangcao tablet work for the treatment of HIV/AIDS:a systematic review of controlled clinical trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, June 2022. http://dx.doi.org/10.37766/inplasy2022.6.0042.
Full textYeates, Elissa, Kayla Cotterman, and Angela Rhodes. Hydrologic impacts on human health : El Niño Southern Oscillation and cholera. Engineer Research and Development Center (U.S.), January 2020. http://dx.doi.org/10.21079/11681/39483.
Full textWang, Yilan, Sijing Zhao, Zherui Shen, Zhenxing Wang, and Fei Wang. Combination of Jinshuibao Capsules and Conventional Pharmaceutical Treatments for Patients with Stable Chronic Obstructive Pulmonary Disease: A Systematic Review and a Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, October 2021. http://dx.doi.org/10.37766/inplasy2021.10.0117.
Full textHaider, Huma. Malaria, HIV and TB in Nigeria: Epidemiology and Disease Control Challenges. Institute of Development Studies (IDS), December 2021. http://dx.doi.org/10.19088/k4d.2022.040.
Full textKanner, Joseph, Mark Richards, Ron Kohen, and Reed Jess. Improvement of quality and nutritional value of muscle foods. United States Department of Agriculture, December 2008. http://dx.doi.org/10.32747/2008.7591735.bard.
Full textCahaner, Avigdor, Susan J. Lamont, E. Dan Heller, and Jossi Hillel. Molecular Genetic Dissection of Complex Immunocompetence Traits in Broilers. United States Department of Agriculture, August 2003. http://dx.doi.org/10.32747/2003.7586461.bard.
Full text